Astria Therapeutics (ATXS)
NASDAQ:ATXS
Holding ATXS?
Track your performance easily

Astria Therapeutics (ATXS) Ownership - Who Owns Astria Therapeutics?

1,037 Followers

Astria Therapeutics (ATXS) Ownership Overview

11.96%18.66%<0.01%10.24%59.15%
11.96% Insiders
<0.01% Other Institutional Investors
10.24% ETFs
59.15% Public Companies and
Individual Investors
The ownership structure of Astria Therapeutics (ATXS) stock is a mix of institutional, retail, and individual investors. Approximately 28.89% of the company’s stock is owned by Institutional Investors, 11.96% is owned by Insiders, and 59.15% is owned by Public Companies and Individual Investors.
The ownership structure of {name} ({ticker}) stock is a mix of institutional, retail, and individual investors. {displayInstitutionalData, select, display {Approximately {institutionalPercentage} of the company’s stock is owned by Institutional Investors} other {}}{displayInsiderText, select, display {, {insidersPercentage} is owned by Insiders} other {}}{displayInvestorsText, select, display {, and {retailInvestorsPercentage} is owned by Public Companies and Individual Investors.} other {}}

Recent Insider Trading Activity

Date
Name
Activity
Value
Feb 05, 2024
xxxxxxxxxxxxx
$29999522
Dec 22, 2023
xxxxxxxxxxxxx
$4588000

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value
Jun 30, 2024
xxxxxxxxxxxxx
$139339
Jun 30, 2024
xxxxxxxxxxxxx
$15924290
Jun 30, 2024
xxxxxxxxxxxxx
$45898179

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
6,485,420Insider11.49%76,852,227
6,485,420Institution11.49%76,852,227
5,043,756Institution8.94%59,768,509
3,554,129Institution6.30%42,116,429
2,697,095Institution4.78%31,960,576
2,471,182Institution4.38%29,283,507
2,130,703Institution3.78%25,248,831
1,822,526Institution3.23%21,596,933
1,749,922Institution3.10%20,736,576
1,043,841Institution1.85%12,369,516

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
2,697,095Institution4.78%31,960,576
2,130,703Institution3.78%25,248,831
1,043,841Institution1.85%12,369,516
978,738Institution1.73%11,598,045
596,256Institution1.06%7,065,634
512,210Institution0.91%6,069,689
508,884Institution0.90%6,030,275
507,811Institution0.90%6,017,560
280,000Institution0.50%3,318,000
228,264Institution0.40%2,704,928

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
1,560,542Institution2.77%17,181,567
1,230,150Institution2.18%14,577,278
599,954Institution1.06%7,091,456
555,181Institution0.98%6,112,543
347,522Institution0.62%4,118,136
302,497Institution0.54%3,584,589
206,603Institution0.37%2,274,699
169,387Institution0.30%2,002,154
102,282Institution0.18%1,212,042
100,758Institution0.18%1,109,346

FAQ

Who Owns Astria Therapeutics (ATXS)?
According to the latest TipRanks data, approximately <0.01% of the company's stock is held by institutional investors, 11.96% is held by insiders, and 59.15% is held by retail investors.
    What percentage of Astria Therapeutics (ATXS) stock is held by institutional investors?
    According to the latest TipRanks data, approximately <0.01% of Astria Therapeutics (ATXS) stock is held by institutional investors.
      What percentage of Astria Therapeutics (ATXS) stock is held by retail investors?
      According to the latest TipRanks data, approximately 59.15% of Astria Therapeutics (ATXS) stock is held by retail investors.
        Who owns the most shares of Astria Therapeutics (ATXS)?
        Perceptive Advisors Llc owns the most shares of Astria Therapeutics (ATXS).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis